# Probiotic and Postbiotic Interactions of Lactobacillus Strains with Candida albicans: Antifungal Effects Through Microbial Competition

**Authors:** Andrea Vega-Vásconez, Diana Lucinda Castillo-Patiño, Javier Alberto Garza-Cervantes, Arlette Santacruz, José Rubén Morones-Ramírez

PMC · DOI: 10.3390/antibiotics15030279 · Antibiotics · 2026-03-10

## TL;DR

This study explores how different forms of lactobacillus bacteria and their byproducts can inhibit the growth of Candida albicans, a harmful fungus, through various mechanisms.

## Contribution

The study systematically compares the antifungal effects of live probiotics, heat-inactivated postbiotics, and cell-free supernatants of lactobacillus strains against Candida albicans.

## Key findings

- Lactobacillus plantarum 299V showed the strongest antifungal effect, reducing Candida albicans viability by 2.39 log10 CFU/mL.
- Antifungal activity of Lactobacillus acidophilus was largely pH-dependent, with inhibition dropping from 79.01% to 28.35% when pH was neutralized.
- Heat-inactivated postbiotics inhibited fungal growth up to 95.14%, but coaggregation with fungal cells may affect measurement accuracy.

## Abstract

Background: Candida albicans is the most clinically significant opportunistic fungal pathogen, and the growing resistance to conventional antifungals, particularly azoles and echinocandins, highlights the urgent need for alternative therapeutic strategies. Although lactic acid bacteria (LAB) have shown inhibitory potential against C. albicans, the relative contributions of live probiotics, heat-inactivated postbiotics, and cell-free supernatants (CFSs) have rarely been compared in parallel under physiologically relevant conditions against a clinical oral isolate. Results: This study systematically evaluated the antifungal activity of Lactiplantibacillus plantarum 299V, Lactobacillus delbrueckii subsp. bulgaricus ATCC 11842, and Lactobacillus acidophilus ATCC 4356 using co-culture assays, minimum inhibitory concentration tests, agar well diffusion assays, and optical microscopy. L. plantarum achieved the strongest inhibitory effect in co-culture, reducing C. albicans viability by 2.39 log10 CFU/mL after 24 h, correlating with the greatest acidification of the culture medium. Methods: CFS from L. acidophilus inhibited fungal growth by 79.01% at native pH, declining to 28.35% upon neutralization to pH 7, confirming that antifungal efficacy is largely pH-dependent and driven by undissociated organic acids. At probiotic concentrations of 1 × 109 CFU/mL, all strains completely suppressed fungal growth. Heat-inactivated postbiotics exhibited up to 95.14% inhibition in MIC assays; however, microscopic analysis revealed coaggregation between postbiotic and fungal cells, which likely interfered with optical density measurements. Conclusions: These findings establish that LAB-mediated antifungal activity is multifactorial and assay-dependent, and highlight the importance of distinguishing between probiotic, postbiotic, and CFS effects when developing LAB-based antifungal strategies.

## Linked entities

- **Species:** Candida albicans (taxon 5476)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), oral candidiasis (MESH:D002180), Fungal infections (MESH:D009181), deaths (MESH:D003643), infections (MESH:D007239), injury to (MESH:D014947), HIV infection (MESH:D015658), systemic disease (MESH:D034721), inflammatory (MESH:D007249), mucosal candidiasis (MESH:D002177), cancer (MESH:D009369)
- **Chemicals:** lipoteichoic acids (MESH:C009900), glycerol (MESH:D005990), NaOH (MESH:D012972), agar (MESH:D000362), lipids (MESH:D008055), phenolphthalein (MESH:D020113), teichoic acids (MESH:D013682), crystal violet (MESH:D005840), Lactic acid (MESH:D019344), azoles (MESH:D001393), IFFI 6005 (-), phenyllactic acid (MESH:C017648), water (MESH:D014867), N (MESH:D009584), dextrose (MESH:D005947), fluconazole (MESH:D015725), echinocandins (MESH:D054714), hydrogen peroxide (MESH:D006861), mineral oil (MESH:D008899), PBS (MESH:D007854), erythromycin (MESH:D004917)
- **Species:** Porphyromonas gingivalis (species) [taxon 837], Lactobacillus acidophilus (species) [taxon 1579], Lactobacillus delbrueckii subsp. bulgaricus (subspecies) [taxon 1585], Candida albicans (species) [taxon 5476], Homo sapiens (human, species) [taxon 9606], Leptospira sp. AB (species) [taxon 103236], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Lacticaseibacillus paracasei (species) [taxon 1597], Lactiplantibacillus plantarum (species) [taxon 1590], Streptococcus mutans (species) [taxon 1309], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562], Klebsiella pneumoniae (species) [taxon 573], Candida [taxon 1535326], Lactobacillus delbrueckii (species) [taxon 1584], Legionella sp. D (species) [taxon 66972], Livupivirus A (no rank) [taxon 1926511]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13023605/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13023605/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC13023605/full.md

---
Source: https://tomesphere.com/paper/PMC13023605